Evidence map›Paper›PMID 33766798›Full record

ArticleActa biomaterialia2021

Sequestered cell-secreted extracellular matrix proteins improve murine folliculogenesis and oocyte maturation for fertility preservation.

Claire E Tomaszewski, Katarina M DiLillo, Brendon M Baker, Kelly B Arnold, Ariella Shikanov

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Claire E TomaszewskiDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: cetomas@umich.edu.
Katarina M DiLilloDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: kdilillo@umich.edu.
Brendon M BakerDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: bambren@umich.edu.
Kelly B ArnoldDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: kbarnold@umich.edu.
Ariella ShikanovDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, 48109, USA; Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI, 48109, USA; Macromolecular Science and Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: shikanov@umich.edu.
University of Michigan · US

Funding

Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
Engineering an immuno-isolating hydrogel for restoring ovarian endocrine functionR01EB022033 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHIKANOV, ARIELLA · 2016 to 2019
$1.5M
A microphysiological engineered 3D system to the rescue of ovarian folliclesR01HD099402 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHIKANOV, ARIELLA · 2020 to 2022
$1.1M
Engineering the ovarian microenvironment and deciphering folliculogenesis in a biomimetic matrixF31HD100069 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TOMASZEWSKI, CLAIRE ELIZABETH · 2019 to 2022
$95k
NIBIB NIH HHS R01 EB022033NICHD NIH HHS F31 HD100069NICHD NIH HHS R01 HD099402NIDCR NIH HHS T32 DE007057
6 · The paper itself

Abstract

Synthetic matrices offer a high degree of control and tunability for mimicking extracellular matrix functions of native tissue, allowing the study of disease and development in vitro. In this study, we functionalized degradable poly(ethylene glycol) hydrogels with extracellular matrix (ECM)-sequestering peptides aiming to recapitulate the native ECM composition for culture and maturation of ovarian follicular organoids. We hypothesized that ECM-sequestering peptides would facilitate deposition and retention of cell-secreted ECM molecules, thereby recreating cell-matrix interactions in otherwise bioinert PEG hydrogels. Specifically, heparin-binding peptide from antithrombin III (HBP), heparan sulfate binding peptide derived from laminin (AG73), basement membrane binder peptide (BMB), and heparan sulfate binding region of placental growth factor 2 (RRR) tethered to a PEG hydrogel significantly improved follicle survival, growth and maturation compared to PEG-Cys, a mechanically similar but biologically inert control. Immunohistochemical analysis of the hydrogel surrounding cultured follicles confirmed sequestration and retention of laminin, collagen I, perlecan, and fibronectin in ECM-sequestering hydrogels but not in bioinert PEG-Cys hydrogels. The media from follicles cultured in PEG-AG73, PEG-BMB, and PEG-RRR also had significantly higher concentrations of factors known to regulate follicle development compared to PEG-Cys. PEG-AG73 and PEG-BMB were the most beneficial for promoting follicle maturation, likely because AG73 and BMB mimic basement membrane interactions which are crucial for follicle development. Here we have shown that functionalizing PEG with ECM-sequestering peptides allows cell-secreted ECM to be retained within the hydrogels, restoring critical cell-matrix interactions and promoting healthy organoid development in a fully synthetic culture system. STATEMENT OF SIGNIFICANCE: Here we present a novel approach for sequestering and retaining cell-secreted extracellular matrix in a fully synthetic material for organoid culture. We have engineered a biomimetic poly(ethylene glycol) hydrogel functionalized with extracellular matrix-binding peptides to recapitulate the ovarian microenvironment. Incorporation of these peptides allows ovarian follicles to recreate their native matrix with the sequestered ECM that subsequently binds growth factors, facilitating follicle maturation. The novel design resulted in improved outcomes of folliculogenesis, potentially developing a fertility preservation option for young women undergoing sterilizing treatments for cancer. The fully synthetic and modular nature of this biomimetic material holds promise for other tissue engineering applications as it allows encapsulated cells to rebuild their native microenvironments in vitro.

Indexed as

Extracellular Matrix ProteinsFertility PreservationAnimalsExtracellular MatrixFemaleHumansHydrogelsMiceOocytesPlacenta Growth FactorPolyethylene GlycolsExtracellular Matrix ProteinsHydrogelsPlacenta Growth FactorPolyethylene GlycolsBiomimetic hydrogelExtracellular matrixOvarian follicle

Identifiers

PMID33766798
PMCPMC8434940
OpenAlexW3138914103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.